New York, Jan. 07, 2025 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) has announced the 2024 Leading Research Achievements by BBRF grantees, prizewinners, and scientific council members. It includes important studies of suicide, childhood anxiety, depression, eating disorders, cocaine addiction, and other aspects of brain and behavior illness.
The 2024 Leading Research Achievements are:
Suicide Risk Fluctuates Across the Menstrual Cycle, Affecting Different Women Differently
Tory Anne Eisenlohr-Moul, Ph.D., University of Illinois, Chicago
Preliminary Trial of Psychoactive Drug Ibogaine Yields ‘Initial Evidence’ for Powerful Therapeutic Potential
Nolan R. Williams, M.D., Stanford University
In Childhood Anxiety, CBT Helps By Normalizing Hyperactive Brain Circuits, Study Finds
Simone P. Haller, D. Phil, National Institute of Mental Health
How Immune Activation May Alter the Brain and Cause Depression-Related Behavior During Chronic Social Stress
Scott J. Russo, Ph.D., Icahn School of Medicine at Mount Sinai
Flurin Cathomas, M.D., Mount Sinai / Psychiatric University Hospital Zurich
A Food-Seeking Circuit in the Brain That Can Override Hunger or “Fullness” Signals May Shed Light on Eating Disorders
Fernando M. C. V. Reis, Ph.D., University of California, Los Angeles
Avishek Adhikari, Ph.D., University of California, Los Angeles
A Stem Cell-Based Therapeutic ‘Rescue Strategy’ is Developed for Timothy Syndrome, an Autism Spectrum Disorder
Sergiu P. Pasca, M.D., Stanford University
New First-in-Class Schizophrenia Medicine Reduced Positive and Negative Symptoms in Decisive Phase 3 Trials
Steven M. Paul, M.D., Karuna Therapeutics
Carol A. Tamminga, M.D., University of Texas (UT) Southwestern Medical School
Study of One Psychedelic Drug Suggests How It Might be Modified to Eliminate Psychedelic Effects While Retaining Therapeutic Ones
Lyonna F. Parise, Ph.D., Icahn School of Medicine at Mount Sinai
Experiments Point to Possible Next-Gen Drug Therapies for Bipolar Disorder, Including for Lithium Non-Responders
Anouar Khayachi, Ph.D., McGill University
Team Develops an Innovative, Implantable Ultrasound Device to Stimulate Neurons in Deep-Brain Regions
Canan Dağdeviren, Ph.D., Massachusetts Institute of Technology
Network Connectivity Patterns in High-Risk Pre-Adolescents Correctly Predicted Depression Symptom Onset 2 Years Later
Dylan G. Gee, Ph.D., Yale University
Researchers Develop ‘Mood Instability’ Measures to Re-Think How Best to Care for Bipolar Disorder Patients
Sarah H. Sperry, Ph.D., University of Michigan
Evidence Grows of the Effectiveness of Rapid-Acting Brain Stimulation to Treat Bipolar Depression
Nolan R. Williams, M.D., Stanford University
Yvette I. Sheline, M.D., University of Pennsylvania
A Possible Biomarker for Cocaine Misuse and a Novel Treatment for Cocaine Addiction Based on Compound in Rosemary
Kevin T. Beier, Ph.D., University of California Irvine School of Medicine
tDCS Non-Invasive Brain Stimulation Fares Well in Trials for PTSD and Major Depression
Mascha van ’t Wout-Frank, Ph.D., Brown University
Cynthia H. Y. Fu, M.D., Ph.D., King’s College London, UK
A Strategy to Sharply Blunt Addictive Reward From Opioids While Retaining Their Pain-Relieving Properties
Francis S. Lee, M.D., Ph.D., Weill Cornell Medicine
For journal citations and more information about the 2024 Leading Research Achievement researchers and their projects, click HERE.
About Brain & Behavior Research Foundation
The Brain & Behavior Research Foundation awards research grants to develop improved treatments, cures, and methods of prevention for mental illness. These illnesses include addiction, ADHD, anxiety, autism, bipolar disorder, borderline personality disorder, depression, eating disorders, OCD, PTSD, and schizophrenia, as well as research on suicide prevention. Since 1987, the Foundation has awarded more than $461 million to fund more than 5,600 leading scientists around the world. 100% of every dollar donated for research is invested in research. BBRF operating expenses are covered by separate foundation grants. BBRF is the producer of the Emmy® nominated public television series Healthy Minds with Dr. Jeffrey Borenstein, which aims to remove the stigma of mental illness and demonstrate that with help, there is hope.
Myrna Manners Brain & Behavior Research Foundation (718) 986-7255 mmanners@mannersdotson.com
